Market Overview

Benzinga's Top Upgrades

Share:
Related AGN
JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years
Allergan Says FDA Accepts Its NDA Filing Of Oxymetazoline HCI Cream 1.0%
Delta Leads A List Of Buys For This Portfolio Which Is Beating The Market (Seeking Alpha)
Related STR
A Seasoned Dividend ETF Tries To Get Its Groove Back
Earnings Scheduled For February 17, 2016
These Top Dividend Stocks Also Show The Highest Relative Strength (Investor's Business Daily)

Analysts at CLSA upgraded Allergan (NYSE: AGN) from “underperform” to “outperform.” Allergan's shares closed at $91.50 on Friday. Allergan's trailing-twelve-month revenue is $5.61 billion.

Analysts at UBS upgraded Questar (NYSE: STR) from “neutral” to “buy.” Questar's stock closed at $19.37 on Friday. Questar's trailing-twelve-month operating margin is 33.27%.

Analysts at Goldman upgraded Rubicon Technology (NASDAQ: RBCN) from “sell” to “neutral.” Rubicon Technology's shares closed at $10.31 on Friday. Rubicon Technology's PEG ratio is -3.25.

Analysts at Deutsche Bank upgraded Cooper Tire & Rubber (NYSE: CTB) from “hold” to “buy.” Cooper Tire & Rubber's shares closed at $19.94 on Friday. Cooper Tire & Rubber's trailing-twelve-month operating margin is 6.03%.

Latest Ratings for AGN

DateFirmActionFromTo
Apr 2016Piper JaffrayDowngradesOverweightNeutral
Apr 2016Guggenheim SecuritiesInitiates Coverage onNeutral
Apr 2016Goldman SachsReinstatesBuy

View More Analyst Ratings for AGN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AGN + CTB)

View Comments and Join the Discussion!